Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
41) and (4
Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nucleartranslocation via regulating PI3K/Akt pathway
in vivo study of W123 is still in the development stage
50 mg/kg) for 28 consecutive days to establish chronic epilepsy models
3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]propanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-methylbutanamido]-N-({[(1S)-1-carbamoyl-4-[(diaminomethylidene)amino]butyl]carbamoyl}methyl)hexanamide
RBN-2397 Catalog No.:M26339-C 41) and (4RBN 2397 is a potent, accross species and orally active NAD+ competitive inhibitor of PARP7 (IC50<3 nM). RBN 2397 selectively binds to PARP7 (Kd=0. 001 M) and restores IFN signaling. RBN 2397 has the potential for the study of advanced or metastatic solid tumors. Product information CAS Number: 2381037 82 5 Molecular Weight: 523. 43 Formula: C20H23F6N7O3 Chemical Name: 5 {[(2S) 1 (3 oxo 3 {4 [5 (trifluoromethyl)pyrimidin 2 yl]piperazin 1
US$ 179.00
US$ 63.00
US$ 150.00
US$ 60.00
US$ 1149.50
US$ 65.00
US$ 50.00